Search
Home Overview Blog Publications About Us Donate Newsletter Press Room


Summary of testimony before the House Foreign Affairs Committee, Subcommittee on Terrorism, Nonproliferation and Trade by Richard Hayes - Jun 19, 2008 While countries differ widely in the policies they have adopted, in regard to the most consequential of these technologies, the answer is "Yes."
Back From the Dead: What Dog Cloning Means for Our Human Future by Osagie K. Obasogie - Jun 16, 2008 Alternet Brought to you by BioArts International, a Northern California biotech startup, man and his dead best friend can now be, as the company's marketing slogan states, "Best Friends Again." And again. And again . . .
Homo Genesis [PDF] by Marcy Darnovsky - Jun 06, 2008 Bitch Techno enthusiasts are marketing extreme reproductive technologies to gay families in a way that could set us on the road to a new chapter in eugenic experimentation.
Race-specific drugs: regulatory trends and public policy by David E. Winickoff and Osagie K. Obasogie - Jun 04, 2008 Trends in Pharmacological Sciences The need for new regulatory approaches to medicines with race-specific indications is growing more acute.
Red Flags Over Consumer Genetics by Marcy Darnovsky - May 22, 2008 The San Diego Union Tribune GINA is a welcome step, and a long overdue one. But even assuming it's effectively enforced, we're at the beginning of a long and bumpy road.


ESPAÑOL | PORTUGUÊS | RUSSIAN

home | overview | blog | publications | about us | donate | newsletter | press room

CGS • 436 14th Street Suite 700, Oakland CA 94612 USA • • (p) 1.510.625.0819 • (F) 1.510.625.0874